Anqiu Lu'an Pharmaceutical
China 2 duplicate records merged Updated 9 July 2026
Anqiu Lu'an Pharmaceutical is a contract manufacturer based in China. It holds 5 active US drug master files and one valid CEP. Its filings concentrate with MINSA (CR), ARCSA (EC) and NMPA (CN). Its GMP standing is certified by MFDS (Korea), EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 26 September 2025 as VAI.
2
registered plants
1 with an FDA FEI number
16
filings
across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Inspection history
- 26 September 2025 VAI US FDA
- 18 May 2018 VAI US FDA
- 1 April 2016 VAI US FDA
- 20 September 2013 VAI US FDA
- 1 July 2011 NAI US FDA
- 1 October 2009 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Weifang, China | Not on file |
| China, China | 3004261627 |
What they file, and where
| Molecule | Regulators | Docs |
| Acetaminophen | EDQM, SFDA (Saudi Arabia), US FDA | 8 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MINSA (CR) | 8 | None |
| ARCSA (EC) | 3 | None |
| NMPA (CN) | 3 | None |
| INVIMA (CO) | 2 | None |
| MFDS (Korea) | None | 2 |
| EMA | None | 2 |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Anqiu Lu'an Pharmaceutical comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 26 September 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates